Search Results 2141-2150 of 2837 for site:slotspk17.com

1. Venetoclax In Combination With ASTX727 For The Treatment Of Chronic Myelomonocytic Leukemia And Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Long-term Safety Study Of Chronocort In The Treatment Of Participants With Congenital Adrenal Hyperplasia - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib And Nivolumab) To Treat Patients With Advanced Melanoma Or Squamous Cell Head And Neck Cancer, An ImmunoMATCH Pilot Study - Mayo Clinic

   Also, to evaluate the feasibility of molecular characterization based on TMB and gene expression profiling (GEP) (for TIS - tumor inflammation signature) for ...

4. A Multi-Center Trial Of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition And Stereotactic Body Radiotherapy In Prostate Cancer (ASCLEPIuS) - Mayo Clinic

   About this study. The purpose of this study is to establish the maximum tolerable dose of niraparib when combined with prostate stereotactic body ...

5. A Study Of How Current Treatments Impact The Course Of Relapsed Myeloma And The Effect Of The Treatments On The Quality-of-life Measurements. - Mayo Clinic

   The secondary goal is to asses clinical endopoints associated with standard of care therapies for TCR MM, in a real-world setting during 12 months of ...

6. Efficacy And Safety Of Lixivaptan In The Treatment Of Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   The vasopressin V2 receptor antagonist lixivaptan has also been shown to ameliorate polycystic disease manifestations in animal models of the disease. Evidence ...

7. RESET-SLE: A Phase 1/​2 Open-Label Study To Evaluate The Safety And Efficacy Of CABA-201 In Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

   Clinical Trials · RESET-SLE: A Phase 1/​2 Open-Label Study To Evaluate The Safety And Efficacy Of CABA-201 In Subjects With Active Systemic Lupus Erythematosus.

8. Study Of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy In Subjects With Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Study Of Cabozantinib Combined With Atezolizumab Vs. Second Novel Hormonal Therapy In Subjects With Metastatic Castration-Resistant Prostate Cancer. Print ...

9. A Study To See If Tolvaptan Is Safe In Infants And Children Who At Enrollment Are 28 Days To Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) - Mayo Clinic

   The purpose of this study is to evaluate the safety of tolvaptan in pediatric subjects with autosomal recessive polycystic kidney disease (ARPKD). Participation ...

10. Single-Ascending Dose Study Of JK07 In Subjects With HFpEF - Mayo Clinic

    The purpose of this study is to assess the safety and tolerability profile of JK07, administered intravenously, according to protocol-defined dosing regimen.